For more than twenty years, the Cologne native has been intensively involved with the stock market, both professionally and privately. He is particularly passionate about national and international small and micro caps.
He first came into contact with the stock market and shares during his banking apprenticeship. After completing this in 2000, he gained his first journalistic experience in the editorial department of a financial portal. During his subsequent studies in business administration, he also worked in the area of investor relations.
Since then, he has remained true to the capital markets and is excited to report on every newly discovered interesting story - as well as on long-standing success stories.
Commented by Fabian Lorenz
Commented by Fabian Lorenz on June 20th, 2025 | 06:55 CEST
Declaration of war on the pharmaceutical industry? Bayer, Novo Nordisk, and insider tip PanGenomic Health
Has US Health Secretary Robert F. Kennedy Jr. declared war on the traditional pharmaceutical industry? That is certainly what former Trump press secretary and current podcaster Anthony Scaramucci seems to think. The reason for this is the complete overhaul of the US Vaccine Advisory Committee. One company set to benefit from the new US Health Secretary is PanGenomic Health. The Company plans to launch a new digital health and alternative medicine business this year. If it manages to secure even a small share of this billion-dollar market, its share price could multiply. The price target for Novo Nordisk was recently reduced. The stock is working on bottoming out, and there was a success for the blockbuster in the US. Bayer's stock is trending favorably. Regular positive news is currently overshadowing the legal disputes in the US. There was recently some positive news to report there.
Read
Commented by Fabian Lorenz on June 19th, 2025 | 07:05 CEST
Share price speculation thanks to drones and artificial intelligence: Rheinmetall, BioNTech, and NetraMark shares
Drones and artificial intelligence are set to revolutionize entire industries. Listed companies that play a leading role in this transformation hold significant upside potential, such as NetraMark. Using artificial intelligence, the Company helps pharmaceutical and biotech companies shorten development times and reduce costs. NetraMark also aims to help shape industry trends. BioNTech, too, relies on AI for its research, frequently acquiring specialized companies. Perhaps NetraMark will be next? In any case, the Canadians would still be a bargain. Rheinmetall shares, on the other hand, are certainly not cheap. However, the multibillion-euro defense budgets for rearmament in Europe are fueling speculation. In order to be able to deliver not only tanks, howitzers, and ammunition quickly, but also cutting-edge technology, Germany's largest defense contractor is focusing on partnerships. This is evident in its latest partnership, which is expected to enable Rheinmetall to deliver combat and kamikaze drones quickly.
Read
Commented by Fabian Lorenz on June 18th, 2025 | 07:00 CEST
Almonty Industries: Analysts raise target price! 75% Upside Potential! CEO clearly backs Rheinmetall and Co. on CNBC
Anything other than further price increases for Almonty shares in the coming weeks would be a surprise. The tungsten gem is facing a hot summer. The main driver for the share price will be the commissioning of the mega mine in South Korea. Due to the increasing visibility of revenue and profit growth, analysts have significantly raised their price targets for the share. With its unique market position, the Company remains attractively valued compared to its peers. With the planned upcoming NASDAQ listing, the stock is expected to attract greater attention from US investors. That Almonty is gaining more visibility is underscored by CEO Lewis Black's recent interview with CNBC. In it, Black emphasized that Almonty already supplies 85% of its production to the defense sector. Rheinmetall, for example, needs tungsten to harden ammunition.
Read
Commented by Fabian Lorenz on June 17th, 2025 | 07:30 CEST
BUY NOW!? Hensoldt, TUI, and Walmart partner MiMedia
Is the consolidation at Hensoldt already over? The sensor technology specialist's shares got off to a good start this week. The trade fair that began yesterday could provide momentum. Among other things, Hensoldt is showcasing radars used in Ukraine as part of the IRIS-T SLM air defense system. Analysts certainly see upside potential. MiMedia shares are also exciting. Chart-wise, the Walmart partner's stock appears to be on the verge of a breakout. The cloud insider tip's previously announced partnerships should start bearing fruit in the second half of the year. In contrast, TUI shares are currently facing some headwinds. The conflict in the Middle East is weighing on the aviation and tourism industry, and there is a dispute with Airbnb over overtourism.
Read
Commented by Fabian Lorenz on June 17th, 2025 | 07:15 CEST
More than 50% upside potential with European tech! SAP, Zalando, Ionos, and naoo shares
There is a spirit of optimism in the European tech industry. The continent aims to become less dependent on the US, not only in terms of defense, but also in the technology sector. The tariff dispute and Microsoft's blocking of email access at the International Court of Justice are fueling a tech boom in Europe. SAP and Ionos are supporting Schwarz Digits in setting up a hyperscaler. Zalando shares are being recommended as a buy. And the chances for naoo AG to establish a European social network appear better than ever. The Swiss company's shares may be on the verge of a revaluation.
Read
Commented by Fabian Lorenz on June 16th, 2025 | 07:20 CEST
Alarm bells ringing for GOLD and DEFENSE: RENK, Barrick Mining, and comeback story AJN Resources
Is the gold price facing a short squeeze? The ECB is certainly painting a horror scenario. This could have serious consequences for banks and the entire financial system. For gold producers and exploration companies, this means further momentum. While Barrick Mining is a core investment, it is also suffering from home-grown problems. AJN Resources is working on the comeback story of the year in the commodities sector. The valuation is still favorable, and exciting news is on the horizon. In the defense sector, consolidation could already be over. The escalating conflict between Israel and Iran will likely drive the shares of RENK, Rheinmetall, and others. Analysts see potential for RENK to reach a new all-time high, and the Company recently reported an order from outside Europe.
Read
Commented by Fabian Lorenz on June 12th, 2025 | 07:10 CEST
Short squeeze, hedge funds, and summer rally: Plug Power, Novo Nordisk, Power Metallic Mines
Is Power Metallic Mines poised for a summer rally? There are certainly good reasons to believe so: Following the discovery of its world-class multi-metal project, the stock has consolidated healthily. At the same time, further positive drilling results were reported, followed by a massive expansion of the area this week. Now, an extensive new drilling program is getting underway. Plug Power has shown in recent days how quickly a stock can rise by 50%. The insolvency candidate has delivered several pieces of positive news, and a short squeeze could drive the stock further. At Novo Nordisk, investors are realizing that the sell-off in recent months may have been too severe. The stock is working on a new upward trend. A hedge fund and a partnership in the AI sector are providing tailwinds.
Read
Commented by Fabian Lorenz on June 11th, 2025 | 07:00 CEST
Revolution in a billion-dollar market! Argo Living Soils shares surge! Soon to be a takeover target?
Argo Living Soils is focusing on its business model this year and has a clear goal: to revolutionize the construction industry. Nanotechnology is set to make concrete and asphalt more durable and environmentally friendly. Buildings and bridges, for example, will be better protected against earthquakes thanks to this "miracle material." At the same time, emissions will be reduced, as the cement industry is one of the world's biggest polluters. The potential is in the billions. Argo Living is still valued at less than CAD 10 million. If progress is made on the road to market launch, a takeover attempt is likely. CAD 100 million should not be a problem for interested parties. There are several reasons to add this stock to your portfolio.
Read
Commented by Fabian Lorenz on June 10th, 2025 | 07:00 CEST
Up more than 1,000%! Siemens Energy and D-Wave! Insider tip First Hydrogen shares jump after announcement!
Siemens Energy stock is a tenbagger! Anyone brave enough in fall 2023 to buy the shares despite speculation about insolvency can now look forward to a price gain of over 1,000%. The reason is the growing appetite for energy demand from artificial intelligence and quantum computing. The latest news from the Company shows where the journey is headed. In the US, in particular, tech companies are focusing on small modular reactors (SMRs). First Hydrogen is another insider tip in this area. The partnership announced yesterday sounds promising and sent the stock soaring. Its valuation still appears attractive. Anything but favorable is D-Wave Quantum after its 2,000% rally - yet this does not appear to be deterring investors. The latest news is driving the stock further.
Read
Commented by Fabian Lorenz on June 9th, 2025 | 07:15 CEST
BioNTech billion-dollar deal a template for BioNxt Solutions? Bayer shares recommended as a buy!
The billion-dollar deal between BioNTech and Bristol-Myers Squibb was a real bombshell and has revitalized the biotech industry. While analysts are raising their price targets for the German biotech high-flyer, there are also critical voices. Investors are also wondering where Big Pharma will strike next. One potential candidate for a partnership is BioNxt Solutions. The Company aims to simplify drug administration using oral dissolvable films, skin patches, and tablets. Clinical trials are about to begin on the development of its lead product for the easier treatment of multiple sclerosis, and a key patent has just been granted in Europe. Due to its low valuation and universal application possibilities, a complete takeover is also conceivable. And what is Bayer doing? Despite numerous legal proceedings, the stock is performing well in 2025. Analysts see further upside potential and have upgraded the stock.
Read